Our research group develops novel algorithms, bioinformatics pipelines and tools to analyze genomic data with a focus on complex disorders such as cancer and neurodevelopmental disorders. We are highly experienced in Next Generation Sequencing data analysis. We use machine learning based models for disease risk prediction, variant pathogenicity and drug discovery. We have projects using network analysis based approaches for tumor subtype stratification and drug discovery.
